A Case of Depersonalization with Treatment-resistant Depression Successfully Treated with Sertraline-lamotrigine Combination
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Treatment of dissociative identity disorder: leveraging neurobiology to optimize success.
Purcell J, Brand B, Browne H, Chefetz R, Shanahan M, Bair Z Expert Rev Neurother. 2024; 24(3):273-289.
PMID: 38357897 PMC: 10950423. DOI: 10.1080/14737175.2024.2316153.
References
1.
Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J
. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71.
DOI: 10.1001/archpsyc.1961.01710120031004.
View
2.
Sierra M
. Depersonalization disorder: pharmacological approaches. Expert Rev Neurother. 2007; 8(1):19-26.
DOI: 10.1586/14737175.8.1.19.
View
3.
Foguet Q, Alvarez M, Castells E, Arrufat F
. Methylphenidate in depersonalization disorder: a case report. Actas Esp Psiquiatr. 2011; 39(1):75-8.
View
4.
Sar V, Tutkun H, Alyanak B, Bakim B, Baral I
. Frequency of dissociative disorders among psychiatric outpatients in Turkey. Compr Psychiatry. 2000; 41(3):216-22.
DOI: 10.1016/S0010-440X(00)90050-6.
View
5.
Anand A, Charney D, Oren D, Berman R, Hu X, Cappiello A
. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry. 2000; 57(3):270-6.
DOI: 10.1001/archpsyc.57.3.270.
View